TickerFacts.

Company research / CANF

Can-Fite BioPharma Ltd. (CANF)

Build a valuation ↗↓ Download CSV

CIK 0001536196 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Can-Fite BioPharma Ltd. reported revenue of $405.0K. Revenue fell 39.9% from the prior annual period.

Key ratios (year ended 2025-12-31)

n/m
Operating margin
n/m
Net margin
-175.8%
Return on year-end equity
-39.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-09-09

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$405.0K$674.0K$743.0K$810.0K$853.0K$763.0K$2.03M$3.82Mn/an/a
R&D Expense$6.69M$5.76M$5.98M$7.76M$9.85M$11.95M$10.98M$6.08M$5.11M$6.12M
Operating Income-$9.95M-$8.13M-$8.20M-$10.10M-$12.84M-$14.14M-$12.01M-$5.41Mn/an/a
Depreciation & Amortization$24.0K$7.0K$15.0K$14.0K$14.0K$12.0K$14.0K$14.0Kn/an/a
EBITDA-$9.93M-$8.12M-$8.18M-$10.08M-$12.83M-$14.13M-$11.99M-$5.40Mn/an/a
Net Income-$9.83M-$7.88M-$7.63M-$10.17M-$12.62M-$14.44M-$12.62M-$6.57Mn/an/a
EPS (Diluted)-$5.97-$10.86-$17.92-$0.01-$0.03-$0.04n/an/an/an/a
Total Assets$9.51M$9.12M$9.99M$9.28M$20.25M$9.52M$8.17Mn/an/an/a
Shareholders' Equity$5.59M$5.44M$6.24M$4.47M$14.38M$6.07M$2.44M$3.02Mn/an/a
Cash & Equivalents$5.53M$4.83M$4.28M$2.98M$4.39M$8.27M$2.70M$3.62Mn/an/a
Operating Cash Flow-$8.95M-$7.64M-$8.44M-$10.80M-$9.86M-$12.06M-$11.08M-$4.16Mn/an/a
Capital Expenditures$2.0K$5.0K$2.0K$9.0K$11.0K$26.0K$3.0K$33.0Kn/an/a
Free Cash Flow-$8.95M-$7.64M-$8.44M-$10.81M-$9.87M-$12.09M-$11.09M-$4.19Mn/an/a
Dividends Paidn/an/an/an/a$2.59M$715.0Kn/an/an/an/a
Shares Outstanding2.62M994.4Kn/a815.75M815.75M463.77M120.65Mn/an/an/a
Weighted Average Diluted Shares1.65M725.3K426.1K815.75M553.08M358.41Mn/an/an/an/a
EPS (Basic)-$5.97-$10.86-$17.92-$0.01-$0.03-$0.04n/an/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView